Loading stock data…
PETS
$1.71+0.01 (+0.59%)
After Hours$1.75+0.04 (+2.34%)· Last close Jun 9
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PetMed Express, Inc. in the Healthcare sector is trading at $1.71 with a market capitalization of $39M. Wall Street consensus targets $2.15 (1 analysts), implying a +25.7% move over the next 12 months. The stock is currently near its 52-week low of $1.57, remaining 34.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +25.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 23) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$1.71
Potential Downside
0%
Whystock Fair Value$1.71
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers no...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$38.95M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-164.60%
Volume
Today's trading volume
277,102
Recent News
PETS Q4 Earnings Call Focuses on Turnaround Foundation
PetMed says FY26 reset is working. Its Q4 sales top estimates, margins improve, and it stays independent after $4-$4.25 offers and touts B2B expansion.
PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navigating Challenges and Embracing ...
Despite a challenging fiscal year, PetMed Express Inc (PETS) focuses on operational efficiency and strategic initiatives to drive future growth.
PetMed Express (PETS) Q4 2026 Earnings Transcript
Following my remarks, Doug will provide a detailed overview of our financial results. Fiscal year 26 was a pivotal year for PetMed Express. During which we made significant financial, operational, and cultural improvements that are aimed at putting the company back on track for sustainable long term results.
Promising Penny Stocks To Consider In February 2026
As February 2026 begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing a record close. For investors looking beyond well-known stocks, penny stocks—typically representing smaller or newer companies—remain an intriguing area of exploration. Though often seen as a relic of past market trends, these stocks can offer unique growth opportunities when backed by solid financials and resilient balance sheets.
PetMed: Fiscal Q2 Earnings Snapshot
DELRAY BEACH, Fla. AP) — PetMed Express Inc. PETS) on Friday reported a loss of $8.5 million in its fiscal second quarter.